Dental Abscess Organism-Specific Therapy

Updated: Dec 29, 2020
  • Author: Jane M Gould, MD, FAAP; Chief Editor: Jeff Burgess, DDS, MSD  more...
  • Print
Overview

Overview

Most dental abscesses respond to surgical treatment (incision and drainage, root canal, or extraction) and elimination of the source of infection. The addition of antibiotics is not recommended for a localized dental abscess. [1] Antibiotics are indicated if drainage is not possible or if the patient shows signs of systemic involvement or is immunocompromised. [2] The duration of therapy should be 7 days. [3, 4, 5, 6, 7]

Organism-specific therapeutic regimens for dental abscess are provided below, including those for Fusobacterium, Bacteroides, Prevotella, Peptostreptococcus, Streptococcus, and Actinomyces. [8]

Next:

Specific Organisms and Therapeutic Regimens (Adults)

Fusobacterium

Treatment recommendations are listed below:

  • Penicillin VK 500 mg PO TID or penicillin G potassium 2-4 million U IV/IM q4-6h

  • Up to 50% of Fusobacteriumnucleatum and 20% of Fusobacteriumnecrophorum isolates produce beta-lactamases, making them resistant to penicillin, ampicillin, and some cephalosporins [9]

If penicillin allergic:Clindamycin 300-450 mg PO TID-QID or 600-900 mg IV q6-8h

  • Duration of therapy: 7 days

Bacteroides

Treatment recommendations are listed below:

  • Amoxicillin-clavulanate 500 mg/125 mg PO TID or

  • Amoxicillin-clavulanate 875 mg/125 mg PO BID

  • Some Bacteroides species produce beta-lactamase

If penicillin allergic:

Prevotella

Treatment recommendations are listed below:

  • Amoxicillin-clavulanate 500 mg/125 mg PO TID or

  • Amoxicillin-clavulanate 875 mg/125 mg PO BID

  • Duration of therapy: 7 days

  • Approximately 50% of Prevotella species produce beta-lactamases

If penicillin allergic:

  • Cefoxitin 1-2g IV q6h or  metronidazole 250-500 mg PO TID or clindamycin 300-450 mg PO TID-QID or 600-900 mg IV q6-8h

  • Duration of therapy: 7 days

Peptostreptococcus

Treatment recommendations are listed below:

  • Amoxicillin 500 mg PO TID or 1g PO BID or

  • Penicillin VK 250-500 mg PO TID-QID or

  • Penicillin G 2-4 million U IV/IM q4-6h or

  • Clindamycin 300-450 mg PO TID-QID or 600-900 mg IV q6-8h or

  • Cefotetan 2g IV q12h

  • Duration of therapy: 7 days

Streptococcus species

Treatment recommendations are listed below:

  • Amoxicillin 500 mg PO BID or

  • Penicillin V 250-500 mg PO TID-QID or

  • Penicillin G 2-4 million U IV/IM q4-6h or

  • Clindamycin 300-450 mg PO TID-QID or 600-900 mg IV q6-8h or

  • Cefoxitin 1-2g IV q6h or

  • Cefotetan 2g IV q12h

  • Duration of therapy: 7 days

Actinomyces

Treatment recommendations are listed below:

  • Penicillin G 2-4 million U IV/IM q4-6h [7]  or

  • Clindamycin 600 mg IV q8h or

  • Doxycycline 100 mg PO BID

  • Duration of therapy: 7 days

  • All Actinomyces isolates are resistant to ciprofloxacin and metronidazole

Previous
Next:

Specific Organisms and Therapeutic Regimens (Children)

For all weight-based pediatric doses listed below, [10] do not exceed adult dose. [9, 11]

Fusobacterium

Treatment recommendations are listed below:

  • Penicillin VK 25-50 mg/kg/day PO divided TID/QID or

  • Penicillin G potassium 100,000-400,000 U/kg/day IV divided q6h, not to exceed 24 million U/day

  • Up to 50% of Fusobacteriumnucleatum and 20% of Fusobacteriumnecrophorum isolates produce beta-lactamases, making them resistant to penicillin, ampicillin, and some cephalosporins [9]

If penicillin allergic:

  • Clindamycin 30 mg/kg/day PO/IV/IM divided q6-8h or

  • Metronidazole 30-50 mg/kg/day PO or 22.5-40 mg/kg/day IV divided q8h

  • Duration of therapy: 7 days

Bacteroides

Treatment recommendations are listed below:

  • Amoxicillin/clavulanate (dosage based on amoxicillin component)

    • 4:1 dosage form: 20-40 mg/kg/day PO divided q8h, not to exceed 500 mg/125 mg PO TID or

    • 7:1 dosage form: 25-45 mg/kg/day PO divided q12h, not to exceed 875 mg/125 mg PO BID

  • Ampicillin/sulbactam 100-200 mg/kg/day IV divided q6h, not to exceed 4g of ampicillin

  • Some Bacteroides species produce beta-lactamase

If penicillin allergic:

  • Metronidazole 30-50 mg/kg/day PO divided q8h or

  • Cefoxitin 80-160 mg/kg/day IV divided q6h, not to exceed 12 g/day, or

  • Cefotetan 40-80 mg/kg/day IV divided q12h, not to exceed 6 g/day

  • Duration of therapy: 7 days

Prevotella

Treatment recommendations are listed below:

  • Amoxicillin/clavulanate (dosage based on amoxicillin component)

    • 4:1 dosage form: 20-40 mg/kg/day PO divided q8h, not to exceed 500 mg/125 mg PO TID or

    • 7:1 dosage form: 25-45 mg/kg/day PO divided q12h, not to exceed 875 mg/125 mg PO BID

  • Ampicillin/sulbactam 100-400 mg/kg/day IV divided q6h, not to exceed 8 g/d ampicillin

  • Approximately 50% of Prevotella species produce beta-lactamases

If penicillin allergic:

  • Cefoxitin 80-160 mg/kg/day IV divided q6h or

  • Metronidazole 30-50 mg/kg/day PO divided q8h or

  • Clindamycin 30 mg/kg/day PO/IV/IM divided q6-8h

  • Duration of therapy: 7 days

Peptostreptococcus

Treatment recommendations are listed below:

  • Amoxicillin 25-50 mg/kg/day PO divided TID or

  • Penicillin VK 25-50 mg/kg/day PO divided TID/QID or

  • Penicillin G potassium 100,000-400,000 U/kg/day IV divided q6h, not to exceed 24 million U/day, or

  • Clindamycin 30 mg/kg/day PO/IV/IM divided q6-8h or

  • Cefotetan 40-80 mg/kg/day IV divided q12h, not to exceed 6 g/day,

  • Duration of therapy: 7 days

Streptococcus species

Treatment recommendations are listed below:

  • Amoxicillin 25-50 mg/kg/day PO divided TID or

  • PenicillinVK 25-50 mg/kg/day PO divided TID/QID or

  • Penicillin G potassium 100,000-400,000 U/kg/day IV divided q6h, not to exceed 24 million U/day, or

  • Clindamycin 30 mg/kg/day PO/IV/IM divided q6-8h or

  • Cefoxitin 80-160 mg/kg/day IV divided q6h, not to exceed 12 g/day, or

  • Cefotetan 40-80 mg/kg/day IV divided q12h, not to exceed 6 g/day

  • Duration of therapy: 7 days

Actinomyces

Treatment recommendations are listed below:

  • Penicillin G potassium 100,000-400,000 U/kg/day IV divided q6h, not exceed 24 million U/day, or

  • Clindamycin 30 mg/kg/day IV divided q6-8h or

  • Doxycycline (children older than 8 y) 2-4 mg/kg PO once daily or divided BID

  • Duration of therapy: 7 days

  • All Actinomyces isolates are resistant to ciprofloxacin and metronidazole

Previous